Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review

Giovanni Cerasola1, Emilio Nardi, Alessandro Palermo

  • 1Department of Internal Medicine, Cardiovascular and Renal Diseases, University of Palermo, Palermo, Italy. medint@unipa.it

Insights

Left ventricular hypertrophy (LVH) is common in chronic kidney disease (CKD) patients, affecting over 70% with end-stage renal disease. Early detection of LVH and diastolic dysfunction in CKD is crucial for improving cardiovascular outcomes.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Cardiovascular diseases (CVD) are a leading cause of mortality in chronic kidney disease (CKD) patients.
  • Left ventricular (LV) abnormalities, including hypertrophy (LVH) and dysfunction, are highly prevalent in CKD and worsen cardiovascular prognosis.

Purpose of the Study:

  • To review the literature on left ventricular hypertrophy (LVH) in patients with chronic kidney disease (CKD).
  • To understand the prevalence, determinants, and clinical implications of LVH and diastolic dysfunction in CKD.

Main Methods:

  • A literature search was conducted using PubMed for studies on left ventricular hypertrophy (LVH) in chronic kidney disease (CKD).
  • The review considered various definitions of LVH used across different studies.

Main Results:

  • Prevalence of LVH exceeds 70% in end-stage renal disease (ESRD) patients.
  • LVH prevalence increases with declining renal function in earlier stages of CKD.
  • Significant heterogeneity exists in reported LVH prevalence due to variations in study populations, GFR estimation methods, and LVH definitions.

Conclusions:

  • Major determinants of LVH in CKD include hypertension, fluid/electrolyte imbalances, and anemia.
  • Non-hemodynamic factors like RAAS activation, oxidative stress, inflammation, and growth factors also contribute to LVH.
  • LV diastolic dysfunction is common, occurs early, and is linked to heart failure and mortality, even without LVH.
  • Early identification of LVH and LV dysfunction in CKD patients may improve cardiovascular outcomes.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...